LA
ATRA icon

Lee Ainslie’s Atara Biotherapeutics ATRA Stock Holding History

Lee Ainslie’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-251,629
Closed -$9.31M – 361
2023
Q3 		$9.31M Hold
251,629
– – 0.21% 48
2023
Q2 		$10.1M Hold
251,629
– – 0.22% 48
2023
Q1 		$18.2M Sell
251,629
-12
-0% -$1.16K 0.46% 34
2022
Q4 		$20.6M Sell
251,641
-62,592
-20% -$6.52M 0.49% 36
2022
Q3 		$29.7M Hold
314,233
– – 0.67% 31
2022
Q2 		$61.2M Hold
314,233
– – 1.51% 15
2022
Q1 		$73M Hold
314,233
– – 1.28% 19
2021
Q4 		$124M Hold
314,233
– – 1.4% 17
2021
Q3 		$141M Buy
314,233
+6,046
+2% +$2.17M 1.42% 16
2021
Q2 		$120M Buy
308,187
+38,611
+14% +$13.8M 1.13% 15
2021
Q1 		$96.8M Sell
269,576
-23,406
-8% -$10.3M 0.89% 23
2020
Q4 		$144M Buy
292,982
+23,130
+9% +$10.7M 2.3% 16
2020
Q3 		$87.4M Sell
269,852
-312
-0.1% -$106K 1.63% 21
2020
Q2 		$98.4M Buy
270,164
+62,168
+30% +$15.7M 2.07% 14
2020
Q1 		$44.3M Buy
207,996
+9,659
+5% +$3.07M 0.93% 27
2019
Q4 		$81.7M Sell
198,337
-5,822
-3% -$2.01M 1.19% 21
2019
Q3 		$72.1M Buy
204,159
+114,860
+129% +$42.9M 1.06% 23
2019
Q2 		$44.9M Buy
89,299
+54,468
+156% +$38.4M 0.65% 30
2019
Q1 		$34.6M Buy
+34,831
New +$32.4M 0.46% 40

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lee Ainslie's ATRA Position: Q4 2023 in Review

Lee Ainslie sold out of Atara Biotherapeutics (ATRA) in Q4 2023, closing a stake of 251,629 shares — an estimated $9.31M sold.

Lee Ainslie first reported a position in ATRA in Q1 2019 and held it in 19 quarters. The position peaked at $144M in Q4 2020. 89 funds tracked by Wall St. Rank hold ATRA as of Q4 2023.

  • Lee Ainslie reported no remaining Atara Biotherapeutics position as of Q4 2023 after selling out during the quarter.
  • Lee Ainslie sold 251,629 Atara Biotherapeutics shares in Q4 2023, an estimated $9.31M.
  • Lee Ainslie first reported a position in Atara Biotherapeutics in Q1 2019 and held it in 19 quarters.
  • Lee Ainslie's Atara Biotherapeutics position peaked at $144M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2023.

Based on Maverick Capital's 13F filing for Q4 2023, filed 14 Feb 2024.